NOTE: This video is ONLY available to watch in selected countries and geographies
Lambros Tselikas (Villejuif, France) speaks to Interventional News about a recent retrospective study evaluating Liver ASSIST Virtual Parenchyma—the results of which he presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain).
The software simulated the perfused parenchyma from a virtual selective injection point on the proximal cone-beam computed tomography (CBCT). It was compared to the corresponding selective CBCT considered as the ground truth.
“You can have very easily the vascular extraction, tumour-feeding vessels, and more interestingly, you can now test multiple injection points and simulate the associated liver parenchyma,” says Lambros Tselikas.
View abstract no. 544: Evaluation of software predicting selective liver perfusion for embolization planning (Journal of Vascular and Interventional Radiology) here: https://www.jvir.org/article/S1051-0443(21)00739-9/fulltext
This video is sponsored by GE Healthcare.
